Medicare & Medicaid
News articles in this section include actions by federal regulators like the CMS and HHS, as well as information on Medicare and state Medicaid coverage and benefits.
Democratic presidential candidates clashed in some of the strongest terms yet over the "Medicare for All" policy dividing the field at the Nevada debate on Wednesday night.
A Senate bill to control prescription drug prices seemed to have everything it needed: bipartisan backing, President Trump’s endorsement and broad public support.
Per capita health spending for the 160 million Americans in employer-sponsored health plans grew by 4.4% in 2018, the third consecutive year of increases above 4%, according to the latest annual spending report by the Health Care Cost Institute.
Seniors on traditional Medicare were more likely to be a part of a family that has problems paying medical bills compared to beneficiaries on Medicare Advantage (MA), a new study found.
Senator Bernie Sanders is a longtime supporter of “Medicare for all.” “I wrote the damn bill,” he said on a debate stage last summer, and his support for universal health care has helped propel him to the front of the 2020 Democratic field.
The Trump administration’s effort to remake Medicaid by requiring low-income people to work for health care suffered a serious setback Friday when a federal appeals court ruled it goes beyond what’s allowed by law.
Several Democratic presidential hopefuls are pitching a federal “public option” as a way to expand health coverage and make it more affordable. The details of their proposals vary, but the general idea is to create a government-sponsored plan that could compete with private insurance.
Almost the entire health care industry is lined up against “Medicare for All.” Hospitals oppose it. Insurance companies oppose it. Drug companies oppose it.
Medicare program managers want to give health insurers more flexibility over pay for agents and brokers.
President Donald Trump on Monday unveiled his fiscal 2021 budget plan to Congress, which is devoid of details on two of the most prominent healthcare policy issues on the 2020 campaign trail: large-scale healthcare reform and prescription drug pricing.